|
|
|
|
|
|
Sponsors and Collaborators: |
National Center for Research Resources (NCRR) Children's Hospital of Philadelphia |
Information provided by: | Office of Rare Diseases (ORD) |
ClinicalTrials.gov Identifier: | NCT00006138 |
OBJECTIVES:
I. Determine the frequency and severity of osteopenia and osteoporosis in patients with thalassemia major who undergo dual energy x-ray absorptiometry, and correlate these findings with other relevant endocrinologic measurements.
Condition |
Osteoporosis Thalassemia Major Osteopenia |
Genetics Home Reference related topics: | beta thalassemia |
MedlinePlus related topics: | Osteoporosis Thalassemia |
Study Type: | Observational |
Study Design: | Screening |
Estimated Enrollment: | 35 |
Study Start Date: | June 1998 |
Estimated Study Completion Date: | August 2000 |
PROTOCOL OUTLINE:
Patients undergo dual energy x-ray absorptiometry for bone density measurements, height (sitting and standing) and weight measurements, comprehensive endocrinologic examination, and assessment of the severity of iron overload at baseline, and then at years 1 and 2.
Ages Eligible for Study: | 6 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
National Center for Research Resources (NCRR) |
Children's Hospital of Philadelphia |
Study Chair: | Alan Richard Cohen | Children's Hospital of Philadelphia |
Study ID Numbers: | 199/15314, CHP-IRB-1998-6-1502, CHP-GCRC-1655 |
First Received: | August 3, 2000 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00006138 |
Health Authority: | United States: Federal Government |
|
|
|
|